Title:
【発明の名称】メラノーマに対する腫瘍ワクチンとしてのGP75
Document Type and Number:
Japanese Patent JP3336006
Kind Code:
B2
Abstract:
The present invention provides an isolated nucleic acid molecule whose sequence encodes the amino acid sequence for a gp75 fragment. The present invention further provides an isolated cDNA molecule of the gp75 fragment nucleic acid molecule and the amino acid sequence derived therefrom. This invention also provides vaccines for stimulating or enhancing in a subject to whom the vaccine is administered production of antibodies directed against gp75 fragments. This invention further provides methods using the vaccines of this invention for stimulating or enhancing production of antibodies against a gp75 fragment as well as for treating, preventing or delaying the recurrence or cancer.
Inventors:
Hofton, Alan N
Vijaya Saraday, Setari
Vijaya Saraday, Setari
Application Number:
JP50783191A
Publication Date:
October 21, 2002
Filing Date:
March 22, 1991
Export Citation:
Assignee:
Sloan-Kettering Institute for Cancer Research
International Classes:
A61K31/65; A61K35/36; A61K38/00; A61K39/00; A61K48/00; A61P35/00; C07K14/47; C12N9/02; C12N15/09; C12N15/12; C12N15/53; C12N15/63; (IPC1-7): C12N15/09; C07K14/47
Other References:
【文献】Journal fo Investigative Dermatology,90(4)(1988),
Attorney, Agent or Firm:
Takehiko Suzue (4 outside)